original ) (raw )In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme
Frederick Mendelsohn
American Journal of Cardiology, 1982
View PDFchevron_right
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: Therapeutic implications
Thomas Unger
The American Journal of Cardiology, 1987
View PDFchevron_right
Determinants of angiotensin II generation during converting enzyme inhibition
Yves Christen
Hypertension, 1990
View PDFchevron_right
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans
F. Perret
American Heart Journal, 1989
View PDFchevron_right
The angiotensin converting enzyme inhibitors – alternative clinical applications
Miłosz Regulski
Journal of Medical Science, 2014
View PDFchevron_right
Acute and Chronic Effects of Angiotensin-Converting Enzyme Inhibitors on Tissue Angiotensin-Converting Enzyme
Frederick Mendelsohn
Clinical and Experimental Pharmacology and Physiology, 1992
View PDFchevron_right
Angiotensin converting enzyme inhibitors in the treatment of hypertension
Govindasamy Mugesh
2011
View PDFchevron_right
Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension
Timothy Doulton
Hypertension, 2005
View PDFchevron_right
Superactive inhibitors of angiotensin converting enzyme
George Fisher
FEBS Letters, 1979
View PDFchevron_right
Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril)
Emanuel Bravo
Hypertension, 1984
View PDFchevron_right
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
C.A. Dézsi
View PDFchevron_right
A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients
Abul Basher
Journal of the American College of Cardiology, 2001
View PDFchevron_right
Angiotensin converting enzyme inhibitors
Chiranth Chand
View PDFchevron_right
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme
Joseph Roulston
British Medical Journal, 1979
View PDFchevron_right
Pleiotropic benefits and utility of angiotensin converting enzyme inhibitors in current practice
Vishal Chaudhari
International Journal of Research in Medical Sciences, 2021
View PDFchevron_right
Could the Pharmacological Differences Observed Between Angiotensin II Antagonists and Inhibitors of Angiotensin Converting Enzyme be Clinically Beneficial?
Marc de Gasparo
Pharmacology & Toxicology, 1992
View PDFchevron_right
Hypotension During Administration of Angiotensin Converting Enzyme Inhibitor SQ 20,881
jose sancho
The Lancet, 1974
View PDFchevron_right
Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating …
Amanda McBroom
2010
View PDFchevron_right
Angiotensin-converting enzyme inhibition to enhance vascular health--clinical and research models
George Bakris
American journal of hypertension, 2001
View PDFchevron_right
Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study
Jirar Topouchian
Journal of Human Hypertension, 1998
View PDFchevron_right
Angiotensin Converting Enzyme Inhibition in Heart, Kidney, and Serum Studied Ex Vivo after Administration of Zofenopril, Captopril, and Lisinopril
Anique Ducharme
Journal of Cardiovascular Pharmacology, 1991
View PDFchevron_right
A Study on Utilization of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Cardiovascular Diseases
jismi joseph
Asian Journal of Pharmaceutical and Clinical Research, 2018
View PDFchevron_right
Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man
Arthur Roberts
The American Journal of Medicine, 1979
View PDFchevron_right
Angiotensin Converting Enzyme in the Rat Heart: Studies of Its Inhibition in Vitro and Ex Vivo
Frederick Mendelsohn
Clinical and Experimental Pharmacology and Physiology, 1989
View PDFchevron_right
Effects of angiotensin converting enzyme inhibition in patients with stable coronary artery disease: The prevention of events with angiotensin converting enzyme inhibition (PEACE) trial: the PEACE Study investigators
Leon Ferder
Circulation
View PDFchevron_right
Ischemic heart disease: the next target for the angiotensin-converting enzyme inhibitors
Eva Lonn
ACE in Ischemic Heart Disease
View PDFchevron_right
A Review on the Effectiveness of Angiotensin Converting Enzyme Inhibitors in Reducing Cardiovascular Morbidity and Mortality Risks
sadia baig
Pakistan Heart Journal
View PDFchevron_right
Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography
Frederick Mendelsohn
Hypertension, 1988
View PDFchevron_right
Usage of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic hypertensive patients-A Review
Dr Anil Tumkur
2018
View PDFchevron_right
Medicinal Chemistry and Therapeutic Relevance of Angiotensin-Converting Enzyme Inhibitors
Naser Alsharif
The American Journal of Pharmaceutical Education, 2007
View PDFchevron_right
Role of the Renin-Angiotensin System in Blood Pressure Regulation The Cardiovascular Effects of Converting Enzyme Inhibition in Normotensive Subjects
Andreas Niarchos
2015
View PDFchevron_right
Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
Gillian Sanders Schmidler
2010
View PDFchevron_right
Analysis of Angiotensin Converting Enzyme Inhibitors and Antagonists
Pakinaz Khashaba
Sphinx Journal of Pharmaceutical and Medical Sciences
View PDFchevron_right